JP2021523127A5 - - Google Patents
Info
- Publication number
- JP2021523127A5 JP2021523127A5 JP2020561828A JP2020561828A JP2021523127A5 JP 2021523127 A5 JP2021523127 A5 JP 2021523127A5 JP 2020561828 A JP2020561828 A JP 2020561828A JP 2020561828 A JP2020561828 A JP 2020561828A JP 2021523127 A5 JP2021523127 A5 JP 2021523127A5
- Authority
- JP
- Japan
- Prior art keywords
- epitope
- cell epitope
- peptide
- antigenic site
- inflammatory response
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024060650A JP2024095743A (ja) | 2018-05-04 | 2024-04-04 | 限られたｔ細胞炎症反応で標的抗体産生を促進する人工的な無差別ｔヘルパー細胞エピトープ |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862667123P | 2018-05-04 | 2018-05-04 | |
| US62/667,123 | 2018-05-04 | ||
| PCT/US2019/030649 WO2019213555A1 (en) | 2018-05-04 | 2019-05-03 | Artificial promiscuous t helper cell epitopes that facilitate targeted antibody production with limited t cell inflammatory response |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024060650A Division JP2024095743A (ja) | 2018-05-04 | 2024-04-04 | 限られたｔ細胞炎症反応で標的抗体産生を促進する人工的な無差別ｔヘルパー細胞エピトープ |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021523127A JP2021523127A (ja) | 2021-09-02 |
| JP2021523127A5 true JP2021523127A5 (https=) | 2022-02-10 |
Family
ID=68386088
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020561828A Pending JP2021523127A (ja) | 2018-05-04 | 2019-05-03 | 限られたｔ細胞炎症反応で標的抗体産生を促進する人工的な無差別ｔヘルパー細胞エピトープ |
| JP2024060650A Pending JP2024095743A (ja) | 2018-05-04 | 2024-04-04 | 限られたｔ細胞炎症反応で標的抗体産生を促進する人工的な無差別ｔヘルパー細胞エピトープ |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024060650A Pending JP2024095743A (ja) | 2018-05-04 | 2024-04-04 | 限られたｔ細胞炎症反応で標的抗体産生を促進する人工的な無差別ｔヘルパー細胞エピトープ |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20220023400A1 (https=) |
| EP (1) | EP3790581A4 (https=) |
| JP (2) | JP2021523127A (https=) |
| KR (1) | KR20210010873A (https=) |
| CN (1) | CN112218655A (https=) |
| AU (1) | AU2019262609A1 (https=) |
| BR (1) | BR112020022443A2 (https=) |
| CA (1) | CA3099296A1 (https=) |
| MX (1) | MX2020011733A (https=) |
| SG (1) | SG11202010942WA (https=) |
| TW (1) | TWI754817B (https=) |
| WO (1) | WO2019213555A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020240332A1 (ja) * | 2019-05-31 | 2020-12-03 | 株式会社半導体エネルギー研究所 | 半導体装置の作製方法 |
| CN112876570B (zh) * | 2021-02-09 | 2022-07-26 | 中国农业科学院生物技术研究所 | 非洲猪瘟病毒疫苗及其制备方法 |
| KR20250040007A (ko) * | 2022-07-14 | 2025-03-21 | 백시니티, 인크. | Tau 펩타이드 면역원 작제물 |
| CN118812726B (zh) * | 2024-06-26 | 2025-05-16 | 西北民族大学 | 脑心肌炎多抗原表位重组蛋白及其在制备脑心肌炎疫苗中的应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI229679B (en) * | 1998-06-20 | 2005-03-21 | United Biomedical Inc | Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens |
| US6025468A (en) * | 1998-06-20 | 2000-02-15 | United Biomedical, Inc. | Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic LHRH peptides |
| US20140088020A1 (en) * | 1999-08-30 | 2014-03-27 | David S Terman | Composition and Methods for Treatment of Cancer |
| US6906169B2 (en) * | 2001-05-25 | 2005-06-14 | United Biomedical, Inc. | Immunogenic peptide composition comprising measles virus Fprotein Thelper cell epitope (MUFThl-16) and N-terminus of β-amyloid peptide |
| ATE506072T1 (de) * | 2002-09-12 | 2011-05-15 | Univ California | Immunogene und entsprechende antikörper, die spezifisch sind für häufige hochmolekulare aggregations-zwischenprodukte von amyloiden aus proteinen unterschiedlicher sequenz |
| JP5863582B2 (ja) * | 2012-07-02 | 2016-02-16 | 東京エレクトロン株式会社 | プラズマ処理装置、及び温度制御方法 |
| JP6502267B2 (ja) * | 2013-02-18 | 2019-04-17 | スプリング バンク ファーマシューティカルズ，インコーポレイテッド | ワクチンアジュバントおよび治療剤としての短鎖オリゴヌクレオチドの設計 |
| US9102752B2 (en) * | 2013-03-15 | 2015-08-11 | United Biomedical, Inc. | Peptide vaccine for prevention and immunotherapy of dementia of the Alzheimer's type |
| US10450352B2 (en) * | 2016-03-23 | 2019-10-22 | Board Of Regents, The University Of Texas System | Engineered polypeptides for antigen delivery |
-
2019
- 2019-05-03 CA CA3099296A patent/CA3099296A1/en active Pending
- 2019-05-03 WO PCT/US2019/030649 patent/WO2019213555A1/en not_active Ceased
- 2019-05-03 CN CN201980030194.0A patent/CN112218655A/zh active Pending
- 2019-05-03 EP EP19796613.8A patent/EP3790581A4/en active Pending
- 2019-05-03 US US17/053,059 patent/US20220023400A1/en active Pending
- 2019-05-03 MX MX2020011733A patent/MX2020011733A/es unknown
- 2019-05-03 SG SG11202010942WA patent/SG11202010942WA/en unknown
- 2019-05-03 BR BR112020022443-0A patent/BR112020022443A2/pt unknown
- 2019-05-03 JP JP2020561828A patent/JP2021523127A/ja active Pending
- 2019-05-03 AU AU2019262609A patent/AU2019262609A1/en not_active Abandoned
- 2019-05-03 KR KR1020207034978A patent/KR20210010873A/ko not_active Ceased
- 2019-05-06 TW TW108115540A patent/TWI754817B/zh active
-
2024
- 2024-04-04 JP JP2024060650A patent/JP2024095743A/ja active Pending
-
2025
- 2025-05-05 US US19/198,679 patent/US20250262286A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021523127A5 (https=) | ||
| Eugui et al. | Genetically restricted cell-mediated cytotoxicity in cattle immune to Theileria parva | |
| EP1320379B1 (en) | Use of replication-deficient poxvirus vector to boost cd4+ t cell immune response to antigen | |
| EP0322990B1 (en) | Polypeptides and derivatives thereof as well as their use in pharmaceutical and diagnostic compositions | |
| Hasan et al. | Recognition of a unique peptide epitope of the mycobacterial and human heat shock protein 65–60 antigen by T cells of patients with recurrent oral ulcers | |
| Zepp et al. | Pertussis-specific cell-mediated immunity in infants after vaccination with a tricomponent acellular pertussis vaccine | |
| Golovliov et al. | Adjuvanticity of ISCOMs incorporating a T cell-reactive lipoprotein of the facultative intracellular pathogen Francisella tularensis | |
| JP2006020648A5 (https=) | ||
| Kamil et al. | Alum-precipitated autoclaved Leishmania major plus bacille Calmette-Guerrin, a candidate vaccine for visceral leishmaniasis: safety, skin-delayed type hypersensitivity response and dose finding in healthy volunteers | |
| JP2004537308A5 (https=) | ||
| CN102056623A (zh) | 免疫原性组合物 | |
| CN105709221B (zh) | 用于预防和/或治疗人中的hiv疾病的药物组合物 | |
| JP2007505147A5 (https=) | ||
| Ni et al. | Protection against scrub typhus by a plasmid vaccine encoding the 56-KD outer membrane protein antigen gene | |
| Convit et al. | The development of a vaccination model using two microorganisms and its application in leprosy and leishmaniasis | |
| Jertborn et al. | Immunological memory after immunization with oral cholera B subunit-whole-cell vaccine in Swedish volunteers | |
| KR102193304B1 (ko) | Rv2299c-ESAT6-HspX-RipA 융합단백질의 BCG 백신 booster용 조성물 | |
| CN103266119A (zh) | 一种结核杆菌三抗原融合基因疫苗及其制备方法和应用 | |
| Takatsu et al. | The immunogenic peptide for Th1 development | |
| US6200575B1 (en) | Non-toxic immunogens derived from a retroviral regulatory protein antibodies preparation process and pharmaceutical compositions comprising them | |
| CN111607521B (zh) | 缺失ap2iv-1基因的弓形虫弱毒活疫苗及其构建方法 | |
| Slepuškin et al. | Evaluation of the effectiveness of large-scale vaccination against influenza in the USSR | |
| Anderson et al. | Recognition of respiratory syncytial (RS) virus proteins by human and BALB/c CD4+ lymphocytes | |
| CN102258779B (zh) | 四种及四种以上hiv载体基因疫苗序贯及重复应用 | |
| CN101049508A (zh) | 携带结核分支杆菌Ag85B的减毒伤寒杆菌载体疫苗 |